Latest From Biotech Now

Biotech Analyst Optimism: Price Targets Post-IPO

Stock Ticker

In a recent blog post, Bruce Booth of Life Sci VC, writes about the relationship between a forecasted price target of a biotech stock and its current share price. If biotech stocks hit their current targets, it could be a good year, Booth writes: “I’ll close with a thought experiment as an optimist: if, in line with historic data, 45% of the current IPO class hits their price targets at some point over the next Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,

Patients Suffering from Gaucher’s Disease Deserve Better

scientist-eyedropper

Gaucher Disease is one of the over 6,000 rare diseases that affect patients worldwide, representing a frontier of unmet medical need [NCATS, NIH]. The challenges for drug development generally—long and costly research and development timelines—are exacerbated by the inherently small patient populations affected by rare diseases. These patients can be difficult to identify and geographically dispersed and their clinical presentation can be quite disparate, complicating the design and recruitment for clinical trials used to determine Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Partnering in Latin America, According to the Experts

LatinAmerica_205x100_Thumbnail copy

Latin America is a hotbed for biotech activity. I recently sat down with four movers and shakers in Latin American biotech to get their thoughts and perspectives: Alexandre Boggio, Director, Business Development, Sanofi Pharma Brazil Carolina Tremmel, Director, New Business Development, Daiichi Sankyo Brasil Edurdo Tsuru, Director, Business Development Latin America, Mundipharma Thiago Mares Guia, MD, PhD, Medical and Scientific Manager, Bionovis See the interview on YouTube: Biotech in Latin America is growing: The Latin Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Participating in IDSA Stakeholder Group on Antimicrobial Resistance

MRSA

BIO will be participating in a newly formed partnership which will work collaboratively to inform federal policy and find ways to better combat the growing crisis of antimicrobial resistance. Launched yesterday by the Infectious Diseases Society of America (IDSA), which also released foundation principles for the group, the U.S. Stakeholder Forum on Antimicrobial Resistance (S-FAR) will hold its inaugural meeting in Philadelphia next month on October 9th. BIO joins more than 75 other national organizations Read More >

Health, Public Policy  |  1 Comment  |  Email This Post
Tags: , , , ,

GMO Labeling: a Debate for the Well-Fed

R Raymond hi resPhoto

BIO wanted to bring to your attention a great piece by Dr. Richard Raymond, former USDA undersecretary for food safety and scheduled keynoter at this month’s BIO Livestock Biotech Summit. Dr. Raymond wrote for the Feedstuffs Foodlink blog a commentary on the push to source non-GM products and the drive for mandatory labeling: Ben & Jerry’s, which dishes out pricey ice cream, long ago made the claim that its products are made with milk from cows that were not Read More >

Farmer Gene  |  Leave a comment  |  Email This Post